Epistem Announce Agency Agreement With Veritas Japan

03-Sep-2010 - Japan

EpiStem plc announced that its contract research services division has entered into an agreement with the Veritas Corporation to exclusively market and distribute Epistem's scientific research services in Japan. The Veritas agreement will provide Epistem with a sales and marketing presence in Japan and the opportunity to extend its research services, and respond rapidly to market demand.

Epistem's CEO Matthew Walls commented "We are delighted to be working with Veritas. They have a strong scientific sales team and established distribution network. The Japanese drug development market provides us with an important opportunity for growth and the agreement with Veritas will allow us to develop closer links with existing Japanese customers."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances